Guatemala healthcare – IPMS Guatemala http://ipmsguatemala.org/ Mon, 21 Nov 2022 18:16:10 +0000 en-US hourly 1 https://wordpress.org/?v=5.9.3 https://ipmsguatemala.org/wp-content/uploads/2021/10/icon-61-120x120.png Guatemala healthcare – IPMS Guatemala http://ipmsguatemala.org/ 32 32 Transcript: AMN Healthcare Services, Inc., Third Quarter 2022 Earnings Call, November 03, 2022 https://ipmsguatemala.org/transcript-amn-healthcare-services-inc-third-quarter-2022-earnings-call-november-03-2022/ Thu, 03 Nov 2022 07:00:00 +0000 https://ipmsguatemala.org/transcript-amn-healthcare-services-inc-third-quarter-2022-earnings-call-november-03-2022/ Thanks for attending, and welcome to AMN Healthcare’s Third Quarter 2022 Earnings Call. [Operator Instructions] I would now like to hand over to Randle Reece, Senior Director of… S&P Capital IQ 2022 All news about AMN HEALTHCARE SERVICES, INC. Analyst Recommendations for AMN HEALTHCARE SERVICES, INC. 2022 sales 5,116M […]]]>


Thanks for attending, and welcome to AMN Healthcare’s Third Quarter 2022 Earnings Call. [Operator Instructions]
I would now like to hand over to Randle Reece, Senior Director of…

S&P Capital IQ 2022

All news about AMN HEALTHCARE SERVICES, INC.

Analyst Recommendations for AMN HEALTHCARE SERVICES, INC.

2022 sales 5,116M

Net income 2022 441M

Net debt 2022 476M

PER 2022 ratio 12.3x
2022 return
Capitalization 5,188M
5,188M
EV / Sales 2022 1.11x
EV / Sales 2023 1.29x
# of employees 3,800
Floating 85.8%

Chart AMN HEALTHCARE SERVICES, INC.


Duration :

Period :




AMN Healthcare Services, Inc. Technical Analysis Chart |  MarketScreener

Trends Technical Analysis AMN HEALTHCARE SERVICES, INC.

Short term Middle term Long term
Tendencies Neutral Bullish Bullish




Evolution of the income statement

Sale

To buy

Medium consensus TO BUY
Number of analysts ten
Last closing price $119.71
Average target price $142.89
Average Spread / Target 19.4%


]]>
New Center for Global Health Research will strengthen health care and build research capacity in non-communicable diseases https://ipmsguatemala.org/new-center-for-global-health-research-will-strengthen-health-care-and-build-research-capacity-in-non-communicable-diseases/ Wed, 26 Oct 2022 11:12:00 +0000 https://ipmsguatemala.org/new-center-for-global-health-research-will-strengthen-health-care-and-build-research-capacity-in-non-communicable-diseases/ The new center will work with communities in Latin America to develop innovative, low-cost solutions to improve health care for non-communicable diseases, with a focus on indigenous populations. Professor Carlos Gomez-Restrepo, Dean of the Faculty of Medicine at Javeriana University (Colombia), assumes the role of co-director of the Center alongside Professor Bird. Non-communicable diseases (NCDs) […]]]>

The new center will work with communities in Latin America to develop innovative, low-cost solutions to improve health care for non-communicable diseases, with a focus on indigenous populations. Professor Carlos Gomez-Restrepo, Dean of the Faculty of Medicine at Javeriana University (Colombia), assumes the role of co-director of the Center alongside Professor Bird.

Non-communicable diseases (NCDs) are diseases that are not transmitted from person to person, such as mental health problems, cardiovascular and respiratory diseases or diabetes. Globally, they are responsible for 8 out of 10 premature deaths, with the greatest burden in low- and middle-income countries (LMICs).

This includes countries in Latin America, where long-term NCDs are a major cause of disability and poor quality of life. There is a lack of community care to help people manage long-term conditions, with most currently available in hospital settings.

The NIHR Global Health Research Center for Community Management of Long-Term Conditions will bring together researchers from Queen Mary University of London and three sites in Latin America – Universidad Javeriana in Colombia, Universidad Franz Tamayo in Bolivia and Universidad Rafael Landívar in Guatemala.

Working closely with Universidad Javeriana, a leading university in Colombia, the Center will study the best ways to manage long-term conditions, developing interventions using the resources available within the community to modify the factors and behaviors related to the development of long-term NCDs. .

The Center will develop the skills of local researchers and clinicians and host a PhD and Masters program to provide formal training for students from the three countries.

The NIHR Global Health Research Centers program funds research-focused partnerships between LRIC institutes and the UK to conduct high-quality research and build institutional capacity within LMICs to undertake, manage and disseminate high quality applied health research. The Latin American Center is one of five research consortia to have received funding under this new program and is the only one based in Latin America.

Professor Faith Osier, President of the International Union of Immunological Societies and Chair of the NIHR Global Health Research Centers Funding Committee, said: “These new centers are truly groundbreaking – this is the first time we see something like this level of investment. in non-communicable disease research in low- and middle-income countries. The potential for this truly equal partnership between LMIC and UK researchers is immense and we are excited to see the progress the next five years will bring.

Victoria Bird, Principal Investigator and Co-Director of the Center, said, “We are delighted to have been recognized by the NIHR Center for Community Treatment of Long-Term Conditions in Latin America. The Center will be the perfect opportunity to strengthen our existing partnership with PUJ as well as forge new links with institutions in Guatemala and Bolivia. The Center offers a unique opportunity to foster innovation, build research and service capacity, and ultimately improve the quality of life for people with long-term illnesses in Latin America, including people from often overlooked indigenous communities.

Carlos Gomez-Restrepo, MD, MSc, PhD, Dean of the Faculty of Medicine at the Pontificia Universidad Javeriana and the NIHR LEAD Center in Latin America, said, “This is a one-of-a-kind project and a unique opportunity where we hope to form a critical mass of research in Latin America, to ultimately seek solutions and improve the quality of life of people with chronic non-communicable diseases, such as diabetes, hypertension, respiratory diseases and mental illnesses »

Astrid Liliana Sanchez, Vice President of Research at the Pontificia Universidad Javeriana, said: “For the Pontificia Universidad Javeriana, the work that will be carried out with this program is of the utmost importance. This will give us the opportunity to create space for the integration of our body of work in different regions of Colombia, with all its diversity, to support the development of previously non-existent links with other Latin American countries, in articulation with global and interdisciplinary development. ”

/Public release. This material from the original organization/authors may be ad hoc in nature, edited for clarity, style and length. The views and opinions expressed are those of the author or authors. See in full here.

]]>
Health sector COVID relief surveys heat up https://ipmsguatemala.org/health-sector-covid-relief-surveys-heat-up/ Fri, 21 Oct 2022 07:00:00 +0000 https://ipmsguatemala.org/health-sector-covid-relief-surveys-heat-up/ After several periods of supplier relief reporting, the government is keeping its word and stepping up audit and investigation activities. More and more providers are beginning to receive civil investigation requests related to the use of COVID-19 funding, and they are requesting the production of documents including corporate organization descriptions, patient information, contracts and communications […]]]>

After several periods of supplier relief reporting, the government is keeping its word and stepping up audit and investigation activities.

More and more providers are beginning to receive civil investigation requests related to the use of COVID-19 funding, and they are requesting the production of documents including corporate organization descriptions, patient information, contracts and communications with employees, staff and other physicians, Frost Brown Todd’s Derek Staub wrote in a blog for Bloomberg Law on Thursday.

CIDS also include written examinations (written questions to be answered in writing under oath) which can number in the hundreds (written examinations).

The Department of Justice appointed a director of Covid fraud in March. Staub said providers are now beginning to receive CIDs by mail or in person, despite the fact that most PRF requests submitted to the Health Resources and Services Administration are legitimate, Staub wrote.

But the reporting requirements are complex and require a level of accounting that some providers, especially smaller ones, might not be experienced in, other legal experts said.

The DOJ looks for submissions that may violate the False Claims Act or anti-bribery laws. If a supplier receives a request for investigation, Staub said, it means the government thinks the supplier may have documents worth investigating.

An attorney is essential to petitioning the DOJ for an extension of time to deliver massive amounts of information, as well as sorting out the privilege and liability of requested information, and other tasks.

“Many questions and requests regarding CIDs are either irrelevant, overly broad, or protected by privilege,” Staub wrote.

The location, organization and review of the requested information should be followed by the provider and the attorney in search of a common denominator in the documents. Staub said the government was looking for things like patient referrals, lack of patient records, lack of medical consent and sham testing regarding HRSA billing.

Staub said such preparation and attention to detail can not only provide a successful defense, but can expose overpayments that must be returned within 60 days.

“Now is the time to conduct internal audits, track internal complaints, revamp your compliance program, ask your attorney questions, and most importantly, document,” Staub wrote.

]]>
Long COVID fuels rise in post-acute healthcare encounters – https://ipmsguatemala.org/long-covid-fuels-rise-in-post-acute-healthcare-encounters/ Wed, 19 Oct 2022 07:00:00 +0000 https://ipmsguatemala.org/long-covid-fuels-rise-in-post-acute-healthcare-encounters/ The burden of long-COVID is evident in increased healthcare utilization, including stays in long-term care facilities, starting two months after a patient tested positive for SARS-CoV- 2, according to a new study. Investigators analyzed public data from Ontario, Canada, on the rate of health care experienced after COVID-19 infection. Comparisons were made between people who […]]]>

The burden of long-COVID is evident in increased healthcare utilization, including stays in long-term care facilities, starting two months after a patient tested positive for SARS-CoV- 2, according to a new study.

Investigators analyzed public data from Ontario, Canada, on the rate of health care experienced after COVID-19 infection. Comparisons were made between people who tested positive and matched negative and the results were stratified by sex.

Among more than 530,000 matched people, women and men who tested positive for COVID-19 had more overall healthcare encounters per person-year than those who tested negative. Women also had more days in long-term care facilities and more home visits, while men had more days in long-term care and outpatient visits, but fewer home visits in the following months. the infection.

After controlling for sociodemographic factors, comorbidities and pandemic waves, the average number of days of hospitalization per person-year increased by 6.5 (47%) for women and 8.7 (53%) for women. men eight weeks or more after a positive COVID-19 test, the researchers report.

The comparison does not tell the whole story of how SARS-CoV-2 affects post-acute healthcare utilization, the authors wrote in the Canadian Medical Association Journal. That’s because the biggest increases in use occurred in just 1% or fewer of those infected, they said.

Small Subset, Big Problems

“Although most people infected with SARS-CoV-2 had little or no change in healthcare utilization, a small but important subset of people experienced a large increase in their rate of health care utilization,” they wrote.

The findings reveal that a small subset of people experience a “substantial burden of morbidity long after SARS-CoV-2 infection” and will compete for scarce healthcare resources, they added. To put this into context, the authors noted that a family physician with a typical schedule of 20 outpatient visits per day before the pandemic would need to accommodate an additional 100 visits or consultations per year to accommodate the increase if half of his patients had recently contracted SARS. -CoV-2 infection.

“Stakeholders can use these findings to prepare for the health care demand associated with the post-COVID-19 (long COVID) state,” they concluded.

Related Articles:

Older people’s long COVID symptoms are often overlooked, mistaken for aging

Federal report outlines ‘long COVID’ clinical care guidelines

]]>
Vaporizers Market Growth in the Future Scope 2022-2028 | GE Healthcare, Penlon Ltd., Draegerwerk AG & Co. KGaA https://ipmsguatemala.org/vaporizers-market-growth-in-the-future-scope-2022-2028-ge-healthcare-penlon-ltd-draegerwerk-ag-co-kgaa/ Fri, 14 Oct 2022 07:00:00 +0000 https://ipmsguatemala.org/vaporizers-market-growth-in-the-future-scope-2022-2028-ge-healthcare-penlon-ltd-draegerwerk-ag-co-kgaa/ vaporizer market The anesthetic vaporizer is part of the anesthesia machine, which is used to deliver the required concentration of anesthetic agent. SEATTLE, WASHINGTON, U.S., Oct. 14, 2022 /EINPresswire.com/ — Coherent Market Insights Offers Global Study Based Research & Analysis, Global Vaporizers Market Report, Historical & Forecast 2022 -2028 Breakdown Data by Companies, Regions, Types […]]]>

vaporizer market

The anesthetic vaporizer is part of the anesthesia machine, which is used to deliver the required concentration of anesthetic agent.

SEATTLE, WASHINGTON, U.S., Oct. 14, 2022 /EINPresswire.com/ — Coherent Market Insights Offers Global Study Based Research & Analysis, Global Vaporizers Market Report, Historical & Forecast 2022 -2028 Breakdown Data by Companies, Regions, Types and Application. The report has been built using a step-by-step analysis based on professional research. The market environment and expected changes during the forecast period are included in the research. The report includes a comprehensive analysis so that the client can spot potential collusion in the future and determine the best course of action. It sheds light on particular developments, significant growth drivers, and market dynamics, including drivers, challenges, and threats, along with an overview of market segmentation, opportunity mapping, and market dynamics. Barrier Analysis. . An overview of the global vaporizers industry with in-depth market segmentation by type, application, and geography is one of the objectives of the report.

𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗮 𝘀𝗮𝗺𝗽𝗹𝗲 𝘁𝗼 𝗼𝗯𝘁𝗮𝗶𝗻 𝗮𝘂𝘁𝗵𝗲𝗻𝘁𝗶𝗰 𝗮𝗻𝗮𝗹𝘆𝘀𝗶𝘀 𝗮𝗻𝗱 𝗰𝗼𝗺𝗽𝗿𝗲𝗵𝗲𝗻𝘀𝗶𝘃𝗲 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝘁 @ https://www.coherentmarketinsights.com/insight/request-sample/2614

This report is released after extensive research and market analysis. There are also market size estimates, market trends, and industry best practices. For entry marketing, the following topics are covered: strategy, positioning, segmentation, competitive environment and economic forecasts. In-depth vendor product benchmarking, roadmap analysis, alignment to important buying criteria, and industry-specific technology solutions are all accessible. Well-known analytical techniques such as SWOT analysis and Porter’s five forces analysis are used to underpin all data, facts, figures and information in this study. A specialized group of researchers, analysts, and forecasters assist in the various processes that go into producing the Vaporizer report.

Data evaluation:

The report examines various factors including market landscape pattern, distribution status, value chain analysis, and growth scenario. The research continues to present the industry chain framework and an executive summary of the global Vaporizer market development. The definition of the market and its scope are defined in the first section of the market study. The data included in the study has been thoroughly reviewed and validated using various models. The report gives information about estimated sales volume and expected revenue for various applications.

Competitive analysis:

The research report carefully examines the profile of each company. This research area covers capacity, production, revenue, cost, gross margin, sales revenue, consumption, growth rate, supply, future strategies and technology developments. Market players, raw material and equipment suppliers, end users, traders, distributors and other important stakeholders are all examined in the study. The research study offers insights on a wide range of industry participants, competitive environment, potential threats, and future development opportunities, in addition to an in-depth analysis of the Vaporizers market.

GE Healthcare, Penlon Ltd., Draegerwerk AG & Co. KGaA, Rothacher Medical GmbH, Allied Medical Ltd., Intersurgical Ltd.

𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

By product type:

Variable Bypass Vaporizer
Plenum
Plenum vaporizer with electronic control
Metered Flow Vaporizer
Desflurane Vaporizer
Vaporizer for direct injection of volatile anesthetics

By agent type:

Desflurane
Halothane
Enflurane
Others

Per end user:

Hospitals
Surgical centers
Others

𝗥𝗲𝗴𝗶𝗼𝗻𝗮𝗹 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀:

» 𝗡𝗼𝗿𝘁𝗵 𝗔𝗺𝗲𝗿𝗶𝗰𝗮: United States, Canada and Mexico
» 𝗦𝗼𝘂𝘁𝗵 & 𝗖𝗲𝗻𝘁𝗿𝗮𝗹 𝗔𝗺𝗲𝗿𝗶𝗰𝗮: Argentina, Chile, Brazil and others
» 𝗠𝗶𝗱𝗱𝗹𝗲 𝗘𝗮𝘀𝘁 & 𝗔𝗳𝗿𝗶𝗰𝗮: Saudi Arabia, United Arab Emirates, Israel, Turkey, Egypt, South Africa and rest of MEA.
» 𝗘𝘂𝗿𝗼𝗽𝗲: UK, France, Italy, Germany, Spain, BeNeLux, Russia, Nordics and Rest of Europe.
» 𝗔𝘀𝗶𝗮-𝗣𝗮𝗰𝗶𝗳𝗶𝗰: India, China, Japan, South Korea, Indonesia, Thailand, Singapore, Australia and rest of APAC.

Ask for a discount before purchasing this business report: https://www.coherentmarketinsights.com/insight/request-discount/2614

Market Growth: Drivers and Constraints

The study of several aspects that favor the expansion of the market is included in the research report. It consists of drivers and restraints that alter the market positively or negatively. The scope of different market segments and applications that may impact the market in the future is also included in this section.

In-depth stress ratio analysis highlights how they differ from drivers and leaves the potential for tactical planning. Factors that hinder business expansion are crucial as they can be addressed to come up with innovative strategies to seize the profitable opportunities available in the rapidly growing industry. In order to better understand the market, the views of industry experts have also been taken into consideration.

Research methodology :

This research includes up-to-date information on the Vaporizers market size that is succinct and accurate. Markets have undergone significant changes over time, making it difficult to assess the size and condition of the market. In order to help you understand the competitiveness and value scope of the Vaporizers Market in a significantly effective manner, our experts at Coherent Market Insights have assessed the current state of the market and offered a comprehensive analysis. To strengthen their market positions, they use smart growth plans, such as new product launches, technological advancements, patents, collaborations, partnerships, acquisitions, and mergers.

Main highlights of this report:

• Renowned analysts undertook in-depth analysis of pricing data based on product, application and regional terrains.
• A thorough examination of the vendor landscape alongside significant companies could enhance the understanding of the competitive environment of the global market.
• Vital and relevant data on the range of regulatory frameworks governing the market, as well as investments made by many global trade players
• An in-depth look at the various factors driving the overall market share and their impact on global industry forecasts and dynamics
• A thorough understanding of the many opportunities offered by the global market as well as the identification of crucial variables
• An in-depth analysis of the several trends that are currently dominating the global industry that could help review progress in the business world

Report customization:

The report can be effectively adapted to all different ways of working to provide workflow flexibility without getting in the way of your preferred working style. The client can get in touch with our sales team, who will ensure that the report meets your requirements.

To buy the report click here – https://www.coherentmarketinsights.com/insight/buy-now/2614

FAQs:

➣ Which five companies dominate the vaporizer market?
➣ What changes can we expect for the Vaporizer market in the coming years?
➣ Which application and product will capture part of the vaporizer market?
➣ What are the drivers and restraints of the Vaporizer market?
➣ Which local market will grow fastest?
➣ What will be the Vaporizer market CAGR and Size during the forecast?
➣ How big is the market today, how big will it be in 2028 and what will be its growth rate?
➣ What are the barriers to market expansion?
➣ What opportunities and difficulties do the main suppliers encounter in the market?
➣ What are the strategies of the main competitors and who are they?
➣ What are the barriers to entry for new competitors?

𝗧𝗮𝗯𝗹𝗲 𝗼𝗳 𝗖𝗼𝗻𝘁𝗲𝗻𝘁:

1. Research objectives and hypotheses
▪ Research objectives
▪ Assumptions
▪ Abbreviations

2. Competence of the market
▪ Description of the report
– Definition and scope of the market
▪ Executive summary
– Market Extract, by Type
– Market Extract, by Application
– Market extract, by region
▪ Consistent Opportunity Map (COM)

3. Market dynamics, regulation and trend analysis
▪ Market dynamics
– Drivers
– Constraints
– Market opportunities

About Coherent Market Insights:

Coherent Market Insights is a global market intelligence and advisory organization that provides syndicated research reports, custom research reports and advisory services. We are known for our actionable insights and genuine reports in various fields, including aerospace and defense, agriculture, food and beverage, automotive, chemicals and materials, and virtually any field and an exhaustive list of subdomains under the sun. We create value for our clients through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing insights in various post-COVID-19 sectors and to continuing to deliver measurable and sustainable results to our clients.

Mr Shah
Coherent Market Insights Pvt. ltd.
+1 206-701-6702
write to us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

]]>
The best healthcare stocks to invest in today? 2 names to watch https://ipmsguatemala.org/the-best-healthcare-stocks-to-invest-in-today-2-names-to-watch/ Fri, 14 Oct 2022 07:00:00 +0000 https://ipmsguatemala.org/the-best-healthcare-stocks-to-invest-in-today-2-names-to-watch/ Healthcare stocks have been among the best performers in the stock market over the past decade. While the overall stock market has more than doubled since 2009, the SPDR Health Sector Fund (XLV), which tracks healthcare stocks in the S&P 500, more than tripled. Healthcare stocks outperformed the market for a variety of reasons. First, […]]]>

Healthcare stocks have been among the best performers in the stock market over the past decade. While the overall stock market has more than doubled since 2009, the SPDR Health Sector Fund (XLV), which tracks healthcare stocks in the S&P 500, more than tripled. Healthcare stocks outperformed the market for a variety of reasons. First, healthcare is one of the few sectors that is largely immune to economic cycles. When the economy weakens, people may cut back on discretionary spending, but they will still need health care.

Second, health care costs have been rising faster than inflation for many years, and this trend shows no signs of slowing. As a result, healthcare companies have been able to steadily increase their profits at a time when many other companies are struggling to maintain profit margins.

Finally, healthcare stocks tend to be less volatile than the broader market, providing investors with some downside protection. Given these factors, it’s no wonder that healthcare stocks have been investors’ favorites in recent years. With that in mind, here are two large cap healthcare stocks for your list right now.

Health stocks to buy [Or Avoid] Now

1. UnitedHealth Group (UNH stock)

Initially we have UnitedHealth Group (A H). In short, UnitedHealth Group is a diversified health and wellness company. UnitedHealth Group offers a comprehensive portfolio of products and services through two distinct platforms: UnitedHealthcare, which provides health coverage and benefits services; and Optum, which provides technology-based health information and services.

UNH Recent Stock Market News

UnitedHealth Group released its third-quarter 2022 financial results on Friday. In them, the healthcare giant reported third-quarter 2022 earnings of $5.79 per share, with revenue of $80.9 billion. dollars. Those results were stronger than analysts had expected, with earnings of $5.45 per share and revenue estimates of $80.5 billion. Additionally, these revenue numbers represent an increase of approximately 12% over the same period a year prior.

Andrew Witty, Chief Executive of UnitedHealth Group, said in the statement to shareholders, “The strength of our performance reflects the diligence and determination of our colleagues to improve the experience of people across the healthcare system and to make high-quality care simpler, more accessible and more affordable.

UNH Stock Chart

So far this year, UNH stock is up 2.16% at Friday’s close, with shares trading at $513.13 per share.

Source: TD Ameritrade Terms of Service

[Read More] The best stocks to buy now? 4 Semiconductor stocks in a nutshell

2. Eli Lilly & Company (LLY shares)

Then let’s dive into Eli Lilly & Co.. (THERE IS). Eli Lilly & Company is a multinational corporation that manufactures and sells pharmaceutical products. The company focuses on areas such as neuroscience, endocrinology, cancer and immunology.

LLY Recent Stock Market News

Earlier this month, the company announced that it had been approved for fast-track designation from the US FDA for its tirzepatide treatment. In detail, tirzepatide is a treatment for obese or overweight adults with weight-specific comorbidities. For the uninitiated, the FDA grants companies Fast Track designation to facilitate treatment development and expedite drug review to treat serious conditions and address an unmet medical need.

Mike Mason, President of Lilly Diabetes said:We are pleased with the FDA’s decision to grant Fast Track designation for tirzepatide, and look forward to completing our continuing submission next year. “Obesity is a chronic disease that affects the health of nearly 100 million Americans and is a significant contributor to healthcare costs.

LLY Stock Chart

Year-to-date, shares of Eli Lilly & Co have outperformed broader markets, with shares so far up more than 21% in 2022. Meanwhile, at the market close of On Friday, LLY stock is currently trading at $331.39 per share.

LLY Stock
Source: TD Ameritrade Terms of Use

If you enjoyed this article and want to learn how to trade so that you have the best chance of making a profit consistently, you need to check out this YouTube channel.
CLICK HERE NOW!!

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

]]>
Biosimilars have saved the healthcare system $21 billion https://ipmsguatemala.org/biosimilars-have-saved-the-healthcare-system-21-billion/ Wed, 12 Oct 2022 07:00:00 +0000 https://ipmsguatemala.org/biosimilars-have-saved-the-healthcare-system-21-billion/ Biosimilars have saved the healthcare system $21 billion over the past six years, according to a recent report from Amgen. Nearly 40 biosimilars received regulatory approval during this period, with 22 products launched. The report found that these biosimilars gained significant market share during this period and argued that the additional competition could result in […]]]>

Biosimilars have saved the healthcare system $21 billion over the past six years, according to a recent report from Amgen.

Nearly 40 biosimilars received regulatory approval during this period, with 22 products launched. The report found that these biosimilars gained significant market share during this period and argued that the additional competition could result in significant cost savings for the healthcare sector, leading to more resources being allocated to innovative treatments.

The report found that the average selling price of reference products and biosimilars has declined since 2015. For biosimilars, the price has declined at a negative compound annual growth rate of -9% to -24%, while benchmark products fell at a negative CAGR of -4% to -21%.

During the second quarter of 2022, Amgen estimated that total drug spending savings reached $3.2 billion.

Meanwhile, the rate of adoption of biosimilars has increased over the past few years, with early drugs to be launched accumulating greater market share compared to later entrants, according to the report.

Additionally, Amgen postulated that biosimilars are poised to transform the US market and the company is positioning itself to build trust in these drugs as a treatment option among patients, providers and pharmacists.

“Over the next few years, the growing number of commercially available biosimilars is expected to change the treatment landscape, providing more options while creating much-needed space for innovation in the healthcare system,” said Jen. Norton, vice president of US value and access at Amgen. , said in a statement. “We expect to see further expansion of biosimilars in pharmaceutical benefit reimbursement, launches in more therapeutic areas, and the approval of additional interchangeable biosimilars.”

Amgen’s study was released less than two weeks after a report by the Association for Accessible Medicines estimated that generic drugs and biosimilars saved the healthcare system $373 billion in 2021. The study highlighted the effects of biosimilars like Yusimry, the cheaper version of Humira, on reducing autoimmune disease expenditures.

In its report, Amgen said there could be at least seven Humira biosimilar launches next year.

Looking ahead, the report indicates that there will be an expansion of biosimilars in pharmaceutical benefit reimbursement as well as biosimilars in more therapeutic classes.

]]>
3D printing in healthcare market size worth $5.8 billion, globally, by 2030 at a CAGR of 20.10% https://ipmsguatemala.org/3d-printing-in-healthcare-market-size-worth-5-8-billion-globally-by-2030-at-a-cagr-of-20-10/ Tue, 11 Oct 2022 07:00:00 +0000 https://ipmsguatemala.org/3d-printing-in-healthcare-market-size-worth-5-8-billion-globally-by-2030-at-a-cagr-of-20-10/ The 3D Printing in Healthcare Market report provides quantitative analysis of market segments, current trends, estimates, and dynamics. PORTLAND, OREGON, USA, Oct. 11, 2022 /EINPresswire.com/ — 3D printing in the healthcare market generated $1.03 billion in 2020 and is expected to reach $5.84 billion by 2030, growing at a CAGR of 20.1% from 2021 to […]]]>

The 3D Printing in Healthcare Market report provides quantitative analysis of market segments, current trends, estimates, and dynamics.

PORTLAND, OREGON, USA, Oct. 11, 2022 /EINPresswire.com/ — 3D printing in the healthcare market generated $1.03 billion in 2020 and is expected to reach $5.84 billion by 2030, growing at a CAGR of 20.1% from 2021 to 2030. The report provides in-depth analysis of changing market dynamics, major segments, top investment pockets, regional landscape, supply chain, value and the competitive scenario. Technological advancements in 3D printing, personalization and personalization, increasing investment in R&D, and increasing biomedical applications are driving the growth of the global 3D printing market in healthcare market. However, high costs, increasing repayment issues, and lack of skilled labor are hampering the growth of the market. On the other hand, the increase in pharmaceutical applications and the presence of bioprinting tissues and organs present new opportunities in the coming years.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:

Key players of the global healthcare 3D printing market analyzed in the research include 3D Systems Corporation, Formlabs Inc., Exone Company, Materialize NV, General Electric, Organovo Holdings, Inc., Oxferd Performance Materials, Inc. ., SLM Solutions Group AG, Proto Labs and Stratasys Ltd.

https://www.alliedmarketresearch.com/request-sample/834

𝗖𝗼𝘃𝗶𝗱-𝟭𝟵 𝗦𝗰𝗲𝗻𝗮𝗿𝗶𝗼:

• Due to the shortage of equipment needed to increase the number of patients infected with Covid-19, the demand for 3D printing in the healthcare sector has increased during the pandemic.
• However, manufacturers have faced manufacturing and supply chain challenges due to lockdown measures and unavailability of workers. Investors postponed plans for investments in new projects.
• Non-elective surgeries have been postponed, leading to lower demand for 3D printing equipment in healthcare.

https://www.alliedmarketresearch.com/purchase-enquiry/834

Based on components, the systems segment contributed the highest share in 2020, holding more than half of the total share, and is expected to maintain its leading position during the forecast period. However, the materials segment is estimated to show the highest CAGR of 21.2% from 2021 to 2030.

On an end-user basis, the medical and surgical center segment held the highest share in 2020, accounting for nearly two-thirds of the global 3D printing market in the healthcare market, and is expected to maintain its lead. in terms of revenue throughout the forecast period. However, the academic institution segment is expected to witness the largest CAGR of 21.7% from 2021 to 2030.

Based on region, North America accounted for the highest share in 2020, contributing more than two-fifths of the total share, and is expected to continue its dominance by 2030. However, Asia-Pacific is expected to post the fastest CAGR of 21.7% during the forecast period.

𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬

Hemophilia Treatment Market

mouth ulcer treatment market

𝐀𝐥𝐬𝐨 𝐑𝐞𝐚𝐝 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐁𝐥𝐨𝐠

Singapore atrial fibrillation market size, key market – https://singaporehealthcarenews.blogspot.com/2022/10/singapore-atrial-fibrillation-market.html

Singapore Biopharmaceuticals Market — https://singaporehealthcarenews.blogspot.com/2022/10/biopharmaceuticals-market-revenue.html

𝐀𝐕𝐄𝐍𝐔𝐄- 𝐀 𝐒𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐋𝐢𝐛𝐫𝐚𝐫𝐲 𝐋𝐢𝐛𝐫𝐚𝐫𝐲 (𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐨𝐧-𝐝𝐞𝐦𝐚𝐧𝐝, 𝐬𝐮𝐛𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧-𝐛𝐚𝐬𝐞𝐝 𝐩𝐫𝐢𝐜𝐢𝐧𝐠 𝐦𝐨𝐝𝐞𝐥) 𝐎𝐟𝐟𝐞𝐫𝐞𝐝 𝐛𝐲 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:

AMR introduces its subscription-based premium online library Avenue, designed specifically to provide a unique and cost-effective solution for businesses, investors and universities. With Avenue, subscribers can benefit from a comprehensive repository of reports on over 2,000 niche industries and over 12,000 company profiles. Additionally, users can get online access to quantitative and qualitative data in PDF and Excel formats, as well as analyst support, customization, and updated versions of reports.

𝐆𝐞𝐭 𝐚𝐧 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐭𝐡𝐞 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐫𝐞𝐩𝐨𝐫𝐭𝐬 𝐚𝐧𝐲 𝐭𝐢𝐦𝐞 𝐟𝐫𝐨𝐦 𝐚𝐧𝐲 𝐝𝐞𝐯𝐢𝐜𝐞 𝐚𝐧𝐝 𝐚𝐧𝐲𝐰𝐡𝐞𝐫𝐞. Access: https://www.alliedmarketresearch.com/librarymarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 :

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 industry sectors, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior executives from leading companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.

David Correa
Allied Analytics LLP
+ +1-503-894-6022
write to us here
Visit us on social media:
Facebook
Twitter
LinkedIn

]]>
NCH ​​Healthcare System will welcome patients from regional hospitals affected by Hurricane Ian https://ipmsguatemala.org/nch-healthcare-system-will-welcome-patients-from-regional-hospitals-affected-by-hurricane-ian/ Fri, 30 Sep 2022 20:30:00 +0000 https://ipmsguatemala.org/nch-healthcare-system-will-welcome-patients-from-regional-hospitals-affected-by-hurricane-ian/ NCH ​​Healthcare System is receiving 400 patients in the aftermath of Hurricane Ian. NCH ​​Healthcare System has never closed its doors once, even in the face of numerous hurricanes. We remain open today as we continue to offer assistance to our community in times of need. —Paul Hiltz NAPLES, FLORIDA, UNITED STATES, Sept. 30, 2022 […]]]>

NCH ​​Healthcare System is receiving 400 patients in the aftermath of Hurricane Ian.

NCH ​​Healthcare System has never closed its doors once, even in the face of numerous hurricanes. We remain open today as we continue to offer assistance to our community in times of need.

—Paul Hiltz

NAPLES, FLORIDA, UNITED STATES, Sept. 30, 2022 /EINPresswire.com/ — NCH Healthcare System, itself dealing with impacts related to Hurricane Ian, is supporting up to 400 patients transferred from nearby hospitals in our north who have been hardest hit by this catastrophic storm.

Lee Health at Ft. Myers, Fla., 40 miles north of Naples, is evacuating up to 400 patients due to water pressure losses at two of its campuses. Other patients will be transferred in the coming days. The state Agency for Health Care Administration said evacuations were needed at Lee Health because hospitals are required to have proper water pressure for patient care as well as the cooling system. installations.

The NCH health system will receive the vast majority of these patients and has the capacity to handle the emergency influx. We already have everything in place logistically and have activated our emergency response plans. 22 patients arrived from Lee Health yesterday and many more transfers are expected to arrive at our two hospital campuses today and into the weekend.

“The NCH Healthcare System has never closed its doors once, even in the face of numerous hurricanes over the years since our opening in 1956,” said Paul Hiltz, President and CEO of NCH Healthcare System. “And while NCH has suffered its own losses, those doors remain open today as we continue to offer assistance to our community in times of need.”

A stream of staff has stepped into NCH to help our neighbors and help support the influx of patients, as NCH continues to seek more accommodation options to be able to house them during this emergency.

Amanda Lucia
Naples Community Hospital Health System
+16786878405 ext.
write to us here

]]>
Health data governance and its need for regulation https://ipmsguatemala.org/health-data-governance-and-its-need-for-regulation/ Thu, 29 Sep 2022 10:00:00 +0000 https://ipmsguatemala.org/health-data-governance-and-its-need-for-regulation/ Image: Kaspars Grinvalds/Adobe Stock If the COVID-19 pandemic has taught us anything about the use of digital technologies and artificial intelligence, it is that these technologies can be both powerful medicine and a potentially dangerous curse. We have seen that digital tools and AI applications could have a revolutionary impact on public health, disease surveillance, […]]]>
Image: Kaspars Grinvalds/Adobe Stock

If the COVID-19 pandemic has taught us anything about the use of digital technologies and artificial intelligence, it is that these technologies can be both powerful medicine and a potentially dangerous curse.

We have seen that digital tools and AI applications could have a revolutionary impact on public health, disease surveillance, vaccine research and service delivery, to name a few examples. But we have also observed digital or AI-based technologies being used to surveil, monitor populations, restrict free speech and undermine access to information. In the healthcare industry, where privacy and data protection are top priorities, these new technologies can pose major challenges. Let’s dig deeper into what data governance means for healthcare and what’s at stake if emerging technologies are misused in the sector.

SEE: The Data Protection and Privacy Bootcamp Pack (TechRepublic Academy)

What is Data Governance in Healthcare?

Data governance in healthcare aims to ensure that all people, processes and technologies within the healthcare organization use data appropriately. Demographic information, treatment plans, and patient visitation records are some examples of data that are most often subject to health data governance processes and procedures.

Whether it’s a long-term care facility or a family practice, healthcare organizations around the world encounter millions of patients every day. During the care process, protected health information, or PHI, and other types of sensitive information are shared with the healthcare organization and stored in its various systems. Not only is this data sensitive, but it is also subject to various compliance regulations, such as the Health Insurance Portability and Accountability Act (HIPAA). These rules and regulations require healthcare organizations to use, share, and store health information with certain privacy and protection measures throughout the data lifecycle. Following these rules helps organizations avoid non-compliance fines and legal issues while ensuring a better patient experience.

What is the impact of data governance on healthcare?

Without proper data governance procedures and training in place, healthcare organizations risk finding themselves at risk of non-compliance. HIPAA violations in particular can occur at any level of an organization; If an undertrained staff member or an insecure database operates in your organization, chances are they will end up abusing patient data and violating HIPAA regulations. This type of violation can lead to non-compliance, fines, legal issues, poorer patient experience, and even loss of trust within the medical community as a whole. Data governance is the difference between a successful and fully operational facility and one that is shut down by the government.

On the other hand, when data governance principles are successfully applied in the healthcare industry, a host of benefits outside of basic compliance can be realized. Patients are convinced that their information is safe and begin to refer their friends and family members to your network. Data becomes easier to find, label and organize for new business use cases and emerging patient technologies. Less time and energy is spent finding the right datasets for future audits. In other words, data governance goes beyond protecting healthcare organizations and their patients and actually provides them with new opportunities for growth.

The power of digital and AI for sustainable development

No industry or business can afford to forego the benefits of technological progress. In fact, research indicates that digital technology and AI can enhance our capabilities to achieve the United Nations Sustainable Development Goals by 2030.

The potential is particularly huge in the healthcare sector and could include the following:

  • Improved diagnosis and treatment
  • More efficient and resource-optimized healthcare management
  • Better medical education and targeted health financing.

With only eight years to go, and with an estimated half of the world’s population still without access to primary health care, such progress is urgently needed. This of course requires increased investment in digital health systems and essential health technologies. Simultaneously, this forces healthcare organizations to preemptively plan for new data governance and security needs.

Overcoming Obstacles to Health Data Governance

The lack of an overarching global health data governance framework is a major hurdle that needs to be overcome in order to fully leverage the potential of digital technologies and AI in healthcare.

For digital technology to fully contribute to positive health outcomes, we must address and overcome the underlying conditions of inequality and injustice. We must prevent digital technology from being used to mine data for unethical commercial or surveillance purposes, and we must prevent it from discriminating against minorities and vulnerable people in insurance schemes.

At the same time, we must address existing data gaps that disproportionately impact marginalized people, including those of low economic status who lack access to health care or communities where health data are not systematically collected.

As noted in a recently published report by The Lancet and Financial Times Commission on Governance of the Future of Health 2030: Growing Up in a Digital World, it is critical that health data governance mechanisms are implemented to “ simultaneously protecting individual rights, promoting the public good potential of this data, and building a culture of data justice and equity.

Principles of health data governance

It is against this backdrop that Transform Health, a global coalition working to achieve universal health coverage through the use of technology and digital data, is now taking this call to action forward by presenting a comprehensive set of Principles of Health Data Governance, the first global set of principles to guide the use of data in health systems.

The eight principles were developed through an inclusive, civil society-led global consultation process involving more than 200 contributors from over 130 organizations through international and regional workshops, followed by public consultation. opened. The process was designed to gather views and expertise and ensure meaningful engagement of diverse stakeholders from all geographies and sectors. The involvement of young people was a particularly crucial priority for us at the Botnar Foundation; we believe they should be treated as equal partners in the development of policies and practices, especially in the digital and AI sectors.

Although the principles speak to and build on existing standards, one of their key distinguishing features is that they bring a strong human rights and equity perspective to the use of data within and between health systems. For example, the principles emphasize the need to “ensure that the benefits of the use of data and data-driven health systems are equitably shared among all groups and populations, regardless of their social, economic or policies”. They thus focus on universalizing the benefits of digitization of health.

In just four weeks, the principles have been endorsed by more than 80 diverse organizations – from the Partnership for Maternal, Newborn and Child Health, hosted by WHO, to PATH and FIND, the global diagnostics alliance.

World leaders must act now

But the principles are only a first step. They are a crucial step towards developing an authoritative framework for health data governance to support the use of digital technologies and data for the global public good – where all people and communities can share, use and benefit from health data.

At the recent World Health Assembly, we drew attention to this issue and called on world leaders to adopt these principles which have now also been endorsed by the World Bank. We hope that leaders around the world will embrace these principles, as such a global framework would allow us to collectively reap the benefits of digital technologies and data for the global public good and improve the future health and well-being of people from all over the world. responsible manner.

Whether you’re working on healthcare data governance frameworks globally or refining how data governance works within your own healthcare organization, the right training for healthcare professionals can make all the difference. courses like The Data Protection and Privacy Bootcamp Pack from TechRepublic are a great way to give your team the standardized training they need to comply with data governance rules and expectations.

Dr. Ulla Jasper is Head of Governance and Policy at the Botnar Foundation.

Dr. Ulla Jasper is Head of Governance and Policy at the Botnar Foundation.

]]>